These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36518316)

  • 1. High grade glioma radiation therapy on a high field 1.5 Tesla MR-Linac - workflow and initial experience with daily adapt-to-position (ATP) MR guidance: A first report.
    Tseng CL; Chen H; Stewart J; Lau AZ; Chan RW; Lawrence LSP; Myrehaug S; Soliman H; Detsky J; Lim-Fat MJ; Lipsman N; Das S; Heyn C; Maralani PJ; Binda S; Perry J; Keller B; Stanisz GJ; Ruschin M; Sahgal A
    Front Oncol; 2022; 12():1060098. PubMed ID: 36518316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First Experience and Prospective Evaluation on Feasibility and Acute Toxicity of Online Adaptive Radiotherapy of the Prostate Bed as Salvage Treatment in Patients with Biochemically Recurrent Prostate Cancer on a 1.5T MR-Linac.
    Wegener D; Thome A; Paulsen F; Gani C; Boldt J; Butzer S; Thorwarth D; Moennich D; Nachbar M; Müller AC; Zips D; Boeke S
    J Clin Med; 2022 Aug; 11(16):. PubMed ID: 36012885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First 500 Fractions Delivered with a Magnetic Resonance-guided Radiotherapy System: Initial Experience.
    Sahin B; Zoto Mustafayev T; Gungor G; Aydin G; Yapici B; Atalar B; Ozyar E
    Cureus; 2019 Dec; 11(12):e6457. PubMed ID: 32025388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of Isotoxic Dose Escalation and Plan Quality with TDABC Analysis on a 0.35 T MR-Linac (MRL) System in Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided Radiation Therapy (MRgRT) for Primary Pancreatic Cancer.
    Hawranko R; Sohn JJ; Neiderer K; Bump E; Harris T; Fields EC; Weiss E; Song WY
    J Clin Med; 2022 May; 11(9):. PubMed ID: 35566712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Online adaptive MR-guided radiotherapy for rectal cancer; feasibility of the workflow on a 1.5T MR-linac: clinical implementation and initial experience.
    Intven MPW; de Mol van Otterloo SR; Mook S; Doornaert PAH; de Groot-van Breugel EN; Sikkes GG; Willemsen-Bosman ME; van Zijp HM; Tijssen RHN
    Radiother Oncol; 2021 Jan; 154():172-178. PubMed ID: 32976875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial Feasibility and Clinical Implementation of Daily MR-Guided Adaptive Head and Neck Cancer Radiation Therapy on a 1.5T MR-Linac System: Prospective R-IDEAL 2a/2b Systematic Clinical Evaluation of Technical Innovation.
    McDonald BA; Vedam S; Yang J; Wang J; Castillo P; Lee B; Sobremonte A; Ahmed S; Ding Y; Mohamed ASR; Balter P; Hughes N; Thorwarth D; Nachbar M; Philippens MEP; Terhaard CHJ; Zips D; Böke S; Awan MJ; Christodouleas J; Fuller CD;
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1606-1618. PubMed ID: 33340604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal monitoring of Apparent Diffusion Coefficient (ADC) in patients with prostate cancer undergoing MR-guided radiotherapy on an MR-Linac at 1.5 T: a prospective feasibility study.
    Almansour H; Schick F; Nachbar M; Afat S; Fritz V; Thorwarth D; Zips D; Bertram F; Müller AC; Nikolaou K; Othman AE; Wegener D
    Radiol Oncol; 2023 Jun; 57(2):184-190. PubMed ID: 37341194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early experience with MR-guided adaptive radiotherapy using a 1.5 T MR-Linac: First 6 months of operation using adapt to shape workflow.
    de Leon J; Crawford D; Moutrie Z; Alvares S; Hogan L; Pagulayan C; Jelen U; Loo C; Aylward JD; Condon K; Dunkerley N; Heinke MY; Sampaio S; Simon K; Twentyman T; Jameson MG
    J Med Imaging Radiat Oncol; 2022 Feb; 66(1):138-145. PubMed ID: 34643065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4D-MRI driven MR-guided online adaptive radiotherapy for abdominal stereotactic body radiation therapy on a high field MR-Linac: Implementation and initial clinical experience.
    Paulson ES; Ahunbay E; Chen X; Mickevicius NJ; Chen GP; Schultz C; Erickson B; Straza M; Hall WA; Li XA
    Clin Transl Radiat Oncol; 2020 Jul; 23():72-79. PubMed ID: 32490218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective Image Quality and Lesion Assessment in the Setting of MR-Guided Radiation Therapy of Prostate Cancer on an MR-Linac at 1.5 T: A Comparison to a Standard 3 T MRI.
    Almansour H; Afat S; Fritz V; Schick F; Nachbar M; Thorwarth D; Zips D; Müller AC; Nikolaou K; Othman AE; Wegener D
    Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33810410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial clinical experience of Stereotactic Body Radiation Therapy (SBRT) for liver metastases, primary liver malignancy, and pancreatic cancer with 4D-MRI based online adaptation and real-time MRI monitoring using a 1.5 Tesla MR-Linac.
    Hall WA; Straza MW; Chen X; Mickevicius N; Erickson B; Schultz C; Awan M; Ahunbay E; Li XA; Paulson ES
    PLoS One; 2020; 15(8):e0236570. PubMed ID: 32764748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Online adaptive radiotherapy for head and neck cancers on the MR linear Accelerator: Introducing a novel modified Adapt-to-Shape approach.
    Gupta A; Dunlop A; Mitchell A; McQuaid D; Nill S; Barnes H; Newbold K; Nutting C; Bhide S; Oelfke U; Harrington KJ; Wong KH
    Clin Transl Radiat Oncol; 2022 Jan; 32():48-51. PubMed ID: 34849412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Implementation and Initial Experience With a 1.5 Tesla MR-Linac for MR-Guided Radiation Therapy for Gynecologic Cancer: An R-IDEAL Stage 1 and 2a First in Humans Feasibility Study of New Technology Implementation.
    Lakomy DS; Yang J; Vedam S; Wang J; Lee B; Sobremonte A; Castillo P; Hughes N; Mohammedsaid M; Jhingran A; Klopp AH; Choi S; Fuller CD; Lin LL
    Pract Radiat Oncol; 2022; 12(4):e296-e305. PubMed ID: 35278717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A daily end-to-end quality assurance workflow for MR-guided online adaptive radiation therapy on MR-Linac.
    Chen X; Ahunbay E; Paulson ES; Chen G; Li XA
    J Appl Clin Med Phys; 2020 Jan; 21(1):205-212. PubMed ID: 31799753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain stereotactic radiosurgery using MR-guided online adaptive planning for daily setup variation: An end-to-end test.
    Han EY; Wang H; Briere TM; Yeboa DN; Boursianis T; Kalaitzakis G; Pappas E; Castillo P; Yang J
    J Appl Clin Med Phys; 2022 Mar; 23(3):e13518. PubMed ID: 34994101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI-Guided Online Adaptive Stereotactic Body Radiation Therapy of Liver and Pancreas Tumors on an MR-Linac System.
    Stanescu T; Shessel A; Carpino-Rocca C; Taylor E; Semeniuk O; Li W; Barry A; Lukovic J; Dawson L; Hosni A
    Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implementation and feasibility of long-course fractionated MR-guided chemoradiotherapy for patients with esophageal cancer: An R-IDEAL stage 1b/2a evaluation of technical innovation.
    Boekhoff MR; Bouwmans R; Doornaert PAH; Intven MPW; Lagendijk JJW; van Lier ALHMW; Rasing MJA; van de Ven S; Meijer GJ; Mook S
    Clin Transl Radiat Oncol; 2022 May; 34():82-89. PubMed ID: 35372703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric analysis of MR-LINAC treatment plans for salvage spine SBRT re-irradiation.
    Han EY; Yeboa DN; Briere TM; Yang J; Wang H
    J Appl Clin Med Phys; 2022 Oct; 23(10):e13752. PubMed ID: 36004700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical application of a sub-fractionation workflow for intrafraction re-planning during prostate radiotherapy treatment on a 1.5 Tesla MR-Linac: A practical method to mitigate intrafraction motion.
    Willigenburg T; Zachiu C; Bol GH; de Groot-van Beugel EN; Lagendijk JJW; van der Voort van Zyp JRN; Raaymakers BW; de Boer JCJ
    Radiother Oncol; 2022 Nov; 176():25-30. PubMed ID: 36113777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First clinical experiences with a high field 1.5 T MR linac.
    Bertelsen AS; Schytte T; Møller PK; Mahmood F; Riis HL; Gottlieb KL; Agergaard SN; Dysager L; Hansen O; Gornitzka J; Veldhuizen E; ODwyer DB; Christiansen RL; Nielsen M; Jensen HR; Brink C; Bernchou U
    Acta Oncol; 2019 Oct; 58(10):1352-1357. PubMed ID: 31241387
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.